Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Evusheld
Pharma
Evusheld now shares the fate of many other COVID-19 antibodies
Even though AstraZeneca’s Evusheld held out longer than most, the drug has finally met the fate of many other COVID-19 antibodies in the U.S.
Fraiser Kansteiner
Jan 27, 2023 10:20am
NICE advises against Merck's Lagevrio, AZ's Evusheld, 3 others
Nov 16, 2022 10:43am
AstraZeneca withdraws US COVID vaccine application
Nov 10, 2022 9:55am
FDA warns AZ's Evusheld is less effective against new subvariant
Oct 4, 2022 11:15am
AstraZeneca partners with major celebs for COVID campaign
Sep 20, 2022 7:10am
AZ gets key blessing in EU for Evusheld to treat COVID patients
Sep 16, 2022 10:50am
